HCPCS Level II · Drugs administered other than oral method
J1850Injection, kanamycin sulfate, up to 75 mg
Terminated 03/31/2024
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J1850
J1850 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, kanamycin sulfate, up to 75 mg.
It was added to HCPCS effective 01/01/1982, and its current record took effect 04/01/2024.
It was terminated on 03/31/2024 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Kanamycin sulfate 75 mg inj
- Date added
- 01/01/1982
- Action effective
- 04/01/2024
- Termination date
- 03/31/2024
- BETOS
- O1E
Related J18xx codes
- J1800Injection, propranolol hcl, up to 1 mg
- J1805Injection, esmolol hydrochloride, 10 mg
- J1806Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
- J1807Injection, ethacrynate sodium, 1 mg
- J1808Injection, folic acid, 0.1 mg
- J1809Injection, fosdenopterin, 0.1 mg
- J1811Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
- J1812Insulin (fiasp), per 5 units
- J1813Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
- J1814Insulin (lyumjev), per 5 units
- J1815Injection, insulin, per 5 units
- J1817Insulin for administration through dme (i.e., insulin pump) per 50 units
Common questions about J1850
Is HCPCS J1850 still valid?
- No. J1850 was terminated on 03/31/2024.
Does Medicare cover J1850?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.